To increase patient numbers, hereditary MTCs often are combined with sporadic MTCs, without a breakdown by RET risk category or RET mutation [10,25], or even without specifying the number of patients with hereditary or sporadic MTC [26]. Here, RET is linked to medullary thyroid gland carcinoma.